Literature DB >> 20308783

Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association.

Karolien Bettens1, Nathalie Brouwers, Helen Van Miegroet, Ana Gil, Sebastiaan Engelborghs, Peter P De Deyn, Rik Vandenberghe, Christine Van Broeckhoven, Kristel Sleegers.   

Abstract

Replication of genetic association findings in independent studies represents an important validation tool in the search for susceptibility genes for complex diseases such as Alzheimer's disease (AD). In a well-characterized memory-clinic based study comprising 1078 unrelated AD patients and 652 control individuals, we set out to replicate previously reported genome-wide association of four novel risk SNPs with AD and onset age, with first stage p-values ranging from 0.001 to 0.000004. We obtained evidence for association between rs179943, an intronic SNP in ATXN1 at 6p22.3, and affection status (OR = 0.63 (95% CI = 0.44-0.90; nominal p = 0.01)). Overall, our data provided independent support for association of at least one chromosomal locus with AD and warranted a more in-depth investigation of these regions for possible underlying functional variants.

Entities:  

Mesh:

Year:  2010        PMID: 20308783     DOI: 10.3233/JAD-2010-1310

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population.

Authors:  Quan Yuan; Changbiao Chu; Jianping Jia
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

2.  Genome-wide analysis of the heritability of amyotrophic lateral sclerosis.

Authors:  Margaux F Keller; Luigi Ferrucci; Andrew B Singleton; Pentti J Tienari; Hannu Laaksovirta; Gabriella Restagno; Adriano Chiò; Bryan J Traynor; Michael A Nalls
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

3.  Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.

Authors:  Melissa Asher; Juao-Guilherme Rosa; Orion Rainwater; Lisa Duvick; Michael Bennyworth; Ruo-Yah Lai; Sheng-Han Kuo; Marija Cvetanovic
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

4.  Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Authors:  Ramón Cacabelos; Rocío Martínez; Lucía Fernández-Novoa; Juan C Carril; Valter Lombardi; Iván Carrera; Lola Corzo; Iván Tellado; Jerzy Leszek; Adam McKay; Masatoshi Takeda
Journal:  Int J Alzheimers Dis       Date:  2012-03-14

5.  Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.

Authors:  Shanker Swaminathan; Li Shen; Sungeun Kim; Mark Inlow; John D West; Kelley M Faber; Tatiana Foroud; Richard Mayeux; Andrew J Saykin
Journal:  Curr Alzheimer Res       Date:  2012-09       Impact factor: 3.498

Review 6.  Current status on Alzheimer disease molecular genetics: from past, to present, to future.

Authors:  Karolien Bettens; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

7.  Genome-wide association interaction analysis for Alzheimer's disease.

Authors:  Elena S Gusareva; Minerva M Carrasquillo; Céline Bellenguez; Elise Cuyvers; Samuel Colon; Neill R Graff-Radford; Ronald C Petersen; Dennis W Dickson; Jestinah M Mahachie John; Kyrylo Bessonov; Christine Van Broeckhoven; Denise Harold; Julie Williams; Philippe Amouyel; Kristel Sleegers; Nilüfer Ertekin-Taner; Jean-Charles Lambert; Kristel Van Steen
Journal:  Neurobiol Aging       Date:  2014-05-28       Impact factor: 4.673

8.  Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.

Authors:  N Brouwers; C Van Cauwenberghe; S Engelborghs; J-C Lambert; K Bettens; N Le Bastard; F Pasquier; A Gil Montoya; K Peeters; M Mattheijssens; R Vandenberghe; P P De Deyn; M Cruts; P Amouyel; K Sleegers; C Van Broeckhoven
Journal:  Mol Psychiatry       Date:  2011-03-15       Impact factor: 15.992

9.  Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription.

Authors:  Jaehong Suh; Donna M Romano; Larissa Nitschke; Scott P Herrick; Britt A DiMarzio; Volodymyr Dzhala; Jun-Seok Bae; Mary K Oram; Yuejiao Zheng; Basavaraj Hooli; Kristina Mullin; Vincenzo A Gennarino; Wilma Wasco; Jeremy D Schmahmann; Mark W Albers; Huda Y Zoghbi; Rudolph E Tanzi
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

10.  Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.

Authors:  Mark T W Ebbert; Kevin L Boehme; Mark E Wadsworth; Lyndsay A Staley; Shubhabrata Mukherjee; Paul K Crane; Perry G Ridge; John S K Kauwe
Journal:  Alzheimers Dement       Date:  2015-10-09       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.